170 related articles for article (PubMed ID: 38281785)
21. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
[TBL] [Abstract][Full Text] [Related]
22. Lipomatous tumors.
Weiss SW
Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
[TBL] [Abstract][Full Text] [Related]
23. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva.
Schoolmeester JK; Leifer AJ; Wang L; Hameed MR
Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712
[TBL] [Abstract][Full Text] [Related]
24. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
25. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
[TBL] [Abstract][Full Text] [Related]
26. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
27. Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma.
Mantilla JG; Ricciotti RW; Chen EY; Liu YJ; Hoch BL
Mod Pathol; 2019 Apr; 32(4):585-592. PubMed ID: 30420727
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
[TBL] [Abstract][Full Text] [Related]
29. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
31. [Paratesticular liposarcoma: the clinicopathological features of nineteen cases].
Yang SM; Wu RC; Qi SS; You JF
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):17-22. PubMed ID: 34979748
[No Abstract] [Full Text] [Related]
32. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
Song MJ; Cho KJ; Lee JS; Song JS
Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.
Weaver J; Downs-Kelly E; Goldblum JR; Turner S; Kulkarni S; Tubbs RR; Rubin BP; Skacel M
Mod Pathol; 2008 Aug; 21(8):943-9. PubMed ID: 18500263
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Utility Of Fish For MDM2 In Adipocytic Neoplasms.
Sarwar S; Mushtaq S; Hassan U; Maqbool H; Qazi R
J Ayub Med Coll Abbottabad; 2021; 33(4):563-567. PubMed ID: 35124908
[TBL] [Abstract][Full Text] [Related]
36. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
37. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
[TBL] [Abstract][Full Text] [Related]
38. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
39. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
40. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
